Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: L01XD04

Gliolan(5-aminolevulinic acid hydrochloride)

Glioma

Marketing Authorisation Holder: Photonamic GmbH & Co. KG

EMA Authorisation: 07/09/2007

INN: 5-aminolevulinic acid hydrochloride

Indication

Gliolan is indicated in adult patients for visualisation of malignant tissue during surgery for malignant glioma (World Health Organization grade III and IV).

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Gliolan — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.